Lifyorli
NDC 76346-550, Relacorilant, kit, from Corcept Therapeutics Incorporated.
- Product NDC
- 76346-550
- Status
- Listed
- Labeler
- Corcept Therapeutics Incorporated
- Dosage form
- KIT
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220641
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76346-550 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76346-550-03 | 76346055003 | 1 BLISTER PACK in 1 CARTON (76346-550-03) / 1 KIT in 1 BLISTER PACK (76346-550-33) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-025-01) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-100-01) |
| 76346-550-09 | 76346055009 | 3 CARTON in 1 CARTON (76346-550-09) / 1 BLISTER PACK in 1 CARTON (76346-550-03) / 1 KIT in 1 BLISTER PACK (76346-550-33) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-025-01) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-100-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
- 2739562{3 (relacorilant 100 MG Oral Capsule [Lifyorli]) / 6 (relacorilant 25 MG Oral Capsule [Lifyorli]) } Pack [Lifyorli 150 MG, 3-Dose Supply] (BPCK)
- 2739564{9 (relacorilant 100 MG Oral Capsule [Lifyorli]) / 18 (relacorilant 25 MG Oral Capsule [Lifyorli]) } Pack [Lifyorli 150 MG, 9-Dose Supply] (BPCK)
Related lookups
FDA label sections
GET /v1/drugs/labels/6fcebfb5-19d6-4f63-b852-999d68a13729
Use it
Look up 76346-550 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76346-550 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76346-550. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.